Pharmacological treatment of osteoarthritis
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Hyoungyoung | - |
dc.contributor.author | Sung, Yoon-Kyoung | - |
dc.date.accessioned | 2021-07-30T05:00:58Z | - |
dc.date.available | 2021-07-30T05:00:58Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2018-10 | - |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/2673 | - |
dc.description.abstract | Osteoarthritis (OA) is a common chronic degenerative disease, and its prevalence increases with age. For patients with symptomatic OA, pharmacological treatment is suggested if symptoms and function do not improve with non-pharmacological modalities, including exercise, devices, manual therapy, or self-management programs. Attempts have been made to develop medications that prevent the structural progression of OA; however, the pharmacological treatment of OA has focused on the management of pain to improve the functional ability of joints. Clinicians try to prescribe adequate classes and doses of medications for pain relief, considering the affected parts of joints, each patient's comorbidities, and the clinical response to medical treatment, including tolerability and side effects. It is important to titrate the dose of medications as patients' symptoms change over time, maintaining the lowest effective dose for each individual. | - |
dc.language | 중국어 | - |
dc.language.iso | zh | - |
dc.publisher | KOREAN MEDICAL ASSOC | - |
dc.title | Pharmacological treatment of osteoarthritis | - |
dc.title.alternative | 골관절염의 약물치료 | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sung, Yoon-Kyoung | - |
dc.identifier.doi | 10.5124/jkma.2018.61.10.623 | - |
dc.identifier.scopusid | 2-s2.0-85055705426 | - |
dc.identifier.wosid | 000447976100006 | - |
dc.identifier.bibliographicCitation | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, v.61, no.10, pp.623 - 629 | - |
dc.relation.isPartOf | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.citation.title | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.citation.volume | 61 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 623 | - |
dc.citation.endPage | 629 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002395416 | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.subject.keywordPlus | KNEE OSTEOARTHRITIS | - |
dc.subject.keywordPlus | CHONDROITIN SULFATE | - |
dc.subject.keywordPlus | STANDING COMMITTEE | - |
dc.subject.keywordPlus | CONTROLLED-TRIALS | - |
dc.subject.keywordPlus | CLINICAL-TRIAL | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | TASK-FORCE | - |
dc.subject.keywordPlus | METAANALYSIS | - |
dc.subject.keywordPlus | RECOMMENDATIONS | - |
dc.subject.keywordPlus | GLUCOSAMINE | - |
dc.subject.keywordAuthor | Osteoarthritis | - |
dc.subject.keywordAuthor | Drug therapy | - |
dc.subject.keywordAuthor | Pain | - |
dc.identifier.url | https://synapse.koreamed.org/articles/1104637 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.